Valuation Collegium Pharmaceutical, Inc.

Stocks

Market Closed - Nasdaq 06:00:00 16/09/26 am AEST			5-day change	1st Jan Change
21.84 ^USD	-4.25%		-6.55%	-52.83%

09/09	Leerink Partners Initiates Coverage on Collegium Pharmaceutical With Outperform Rating, $45 Price Target	MT
09/09	Truist Cuts Price Target on Collegium Pharmaceutical to $49 From $58, Keeps Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	650	778.9	1,004	924	1,464	711	-	-
Change	-	19.82%	28.87%	-7.95%	58.4%	-51.42%	-	-
Enterprise Value (EV)	650	778.9	1,004	924	1,464	711	711	711
Change	-	19.82%	28.87%	-7.95%	58.4%	-51.42%	0%	0%
P/E	10x	-31.4x	23.9x	15.4x	26.8x	10.8x	5.6x	5.11x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	-0x	0.3x	-3.83x	0.6x	0.1x	0.53x
Capitalization / Revenue	2.35x	1.68x	1.77x	1.46x	1.88x	0.85x	0.84x	0.84x
EV / Revenue	0x	0x	0x	0x	0x	0.85x	0.84x	0.84x
EV / EBITDA	0x	0x	0x	0x	0x	1.56x	1.76x	1.91x
EV / EBIT	0x	0x	0x	0x	0x	1.58x	1.76x	1.89x
EV / FCF	-	-	0x	0x	0x	2.34x	1.99x	1.8x
FCF Yield	-	-	27.3%	22%	22.4%	42.8%	50.2%	55.6%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.86	-0.74	1.29	1.86	1.73	2.02	3.9	4.275
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	276.9	463.9	566.8	631.4	780.6	836.1	842.5	847
EBITDA ¹	118.3	266	367	401.2	460.5	456.6	405	373.1
EBIT ¹	17.63	33.32	167	169.9	179.6	450.8	404.7	376.5
Net income ¹	71.52	-25	48.16	69.19	62.87	72.55	151.5	160
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	18.68	23.20	30.78	28.65	46.30	21.84	21.84	21.84
Nbr of stocks (in thousands)	34,797	33,572	32,611	32,250	31,611	32,556	-	-
Announcement Date	24/2/22	23/2/23	22/2/24	27/2/25	26/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
COLLEGIUM PHARMACEUTICAL, INC.	11.29x	-	-	-	711M
ELI LILLY AND COMPANY	32.41x	11.77x	23.88x	0.61%	1,013B
JOHNSON & JOHNSON	29.62x	6.59x	18.45x	2.02%	644B
ABBVIE INC.	33.52x	7.76x	16.03x	2.62%	465B
ROCHE HOLDING AG	19.65x	4.78x	11.85x	2.77%	352B
NOVARTIS AG	19.69x	5.14x	12.76x	3.13%	264B
ASTRAZENECA PLC	21.05x	4.32x	12.35x	2.04%	253B
AMGEN INC.	24.13x	6.36x	11.33x	2.64%	203B
NOVO NORDISK A/S	12.48x	4.54x	9.49x	4.03%	188B
GILEAD SCIENCES, INC.	-44.28x	6.46x	25.23x	2.25%	181B
Average	15.96x	6.41x	15.71x	2.46%	356.44B
Weighted average by Cap.	23.61x	7.64x	17.63x	2.01%